P. D. Hinduja Hospital & Dr. Homi Bhabha State University join hands to conduct specialized Postgraduate Allied Health Courses

IMT News Desk
IMT News Desk
· 2 min read
P. D. Hinduja Hospital & Dr. Homi Bhabha State University partner to launch PG allied health courses in August 2026

P. D. Hinduja Hospital & Medical Research Centre signed a memorandum of understanding with Dr. Homi Bhabha State University (HBSU) to jointly conduct postgraduate allied (paramedical) health courses.

The MoU aims to address the growing demand for skilled healthcare professionals and strengthen the quality of paramedical education in India. The program, expected to commence in August 2026, will be offered across multiple specialised areas, with an intake of 20-30 students per course.

The country’s healthcare sector faces a critical manpower shortage of approximately 4 million trained paramedical professionals. Leveraging the academic expertise of Dr. Homi Bhabha State University, the clinical strengths of P. D. Hinduja Hospital, and the training expertise of LIHS, this collaboration seeks to bridge this critical gap. It aligns with recent government priorities focused on strengthening allied healthcare education and workforce development.

As part of this initiative, skill-based postgraduate certificate programs will be offered in areas such as Pathology Technician, Dialysis Technician, Operation Theatre Technician (OT), Intensive Care Unit Technician (ICU), Radiology Technician, Medical Records & Health Information Technician, Neurology Technician, Central Sterile Supply Department Technician (CSSD), and Endoscopy Technician. The courses are designed to make students industry-ready within one year through a structured and intense training plan.

Mr. Gautam Khanna, CEO, P. D. Hinduja Hospital & Medical Research Centre, said, “As healthcare increasingly becomes specialized, there is a pressing need to build a strong workforce equipped with practical knowledge and clinical expertise. Through this collaboration with Dr. Homi Bhabha State University, we aim to train industry-ready, highly skilled allied healthcare professionals capable of delivering quality and safe patient care.”

Prof. Vilas Padhye, Registrar of Dr. Homi Bhabha State University, said, “Though young as a university, we carry on our shoulders the rich legacy of over a hundred and fifty years inherited from our constituent colleges. Our commitment to providing quality education and developing skills through the integration of social responsibility and modern technology remains steadfast. Through this collaboration with P. D. Hinduja Hospital, we aim to nurture skilled allied health professionals in healthcare, which is not only a pressing necessity but also a deeply fulfilling mission for us.”

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk